Penn Medicine awarded $14 million NIH grant to apply CAR T immunotherapies to match more patients in need of kidney transplants
The team will launch a clinical trial harnessing synthetic chimeric antigen receptor (CAR) T cells to use with patients for whom a compatible kidney cannot be found due to preexisting antibodies against potential donors.
FULL STORY AT Penn Medicine News →